Results 81 to 90 of about 13,362 (238)

Neuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticus

Pediatric Reports, 2011
Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal disease characterized by fever, muscle rigidity, delirium and autonomic instability. Here we report a child, with NMS due to the risperidone misdiagnosed as status epilepticus.
Ali Ertug Arslankoylu, Meryem Ozlem Kutuk, Cetin Okuyaz, Fevziye Toros   +3 more
doaj   +1 more source

Lorazepam provocation test in purported schizophrenia with lack of treatment response [PDF]

, 2014
Some patients with severe mental disorders are refractory to psychotherapeutic or psychopharmacological interventions. We present a patient who at the age of 19 developed several schizophrenia - suspect symptoms.
Berg, John E.
core   +3 more sources

Neuroleptic malignant syndrome: A review of diagnosis and treatment [PDF]

, 2020
Background Neuroleptic Malignant Syndrome is a life-threatening neuropsychiatric emergency because of the use of Neuroleptic drugs characterized by specifically clinical syndrome, like changes in mental status, stiffness, fever, and dysautonomia.
Putra Patria Yudha, -, Yunias Setiawati, -   +1 more
core   +1 more source

Neuroleptic Malignant Syndrome [PDF]

CNS Drugs, 1990
The neuroleptic malignant syndrome (NMS) is a rare phenomenon that continues to generate controversy. By definition, for its diagnosis NMS requires exposure to drugs that alter dopaminergic function [i.e. neuroleptics (antipsychotics)]. The symptoms of NMS include hyperthermia, extrapyramidal side effects (EPS), altered mental status and autonomic ...
Silvia S. Gratz, George M. Simpson
openaire   +4 more sources

The risk of death after hospitalisation following intentional self‐poisoning: a retrospective observational study (PAVLOVA‐2)

Medical Journal of Australia, EarlyView.
Abstract Objectives To estimate the risk of death after hospitalisation with non‐fatal intentional self‐poisoning in New South Wales, and to estimate the associated number of years of life lost. Study design Retrospective observational study; analysis of Poisoning And enVenomation Linkage to evaluate Outcomes and clinical Variation in Australia ...
Firouzeh Noghrehchi, Nicholas A Buckley, Rose Cairns   +2 more
wiley   +1 more source

Neuroleptic malignant syndrome induced by concomitant use of risperidone and quetiapine

CHRISMED Journal of Health and Research, 2016
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening condition induced by neuroleptic medications. In severe cases, NMS can rapidly lead to death. NMS is reported less frequently now-a-days with the advent of new antipsychotic drugs.
Mustafa Volkan Demir, Tuba Ozturk Demir, Selcuk Yaylaci, Huseyin Yildiz, Ibrahim Tayci, Mustafa Baydar   +5 more
doaj   +1 more source

Osmotic Demyelination Syndrome in a Patient With Schizophrenia: A Case Report

Neuropsychopharmacology Reports, Volume 45, Issue 4, December 2025.
A man with schizophrenia developed osmotic demyelination syndrome after rapid correction of polydipsia‐induced hyponatremia, presenting with pseudobulbar palsy & severe EPS. MRI confirmed pontine and basal ganglia lesions. This report highlights ODS as key differential from antipsychotic side effects.
Yin‐Chen Lai, Chen‐Chia Lan
wiley   +1 more source

Diagnosis in the Neuroleptic Malignant Syndrome [PDF]

, 2011
Neuroleptic malignant syndrome (NMS) is an uncommon, potentially lethal complication of treatment with antipsychotic medication. First described in American journals by Delay and Deniker in 1968 (1), this syndrome has been reported for many years in the ...
Dallman, MD, CPT, MC, James H.
core   +1 more source

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness [PDF]

, 2018
BACKGROUND: There are conflicting data on the effects of antipsychotic medications on delirium in patients in the intensive care unit (ICU). METHODS: In a randomized, double-blind, placebo-controlled trial, we assigned patients with acute ...
Bernard, G.R., Boehm, L.M., Bowton, D.L., Brummel, N.E., Carson, S.S., Chandrasekhar, R., Dittus, R.S., Douglas, I.S., Ely, E.W., Exline, M.C., Feinstein, D.J., Girard, T.D., Gong, M.N., Hite, R.D., Hough, C.L., Hughes, C.G., Hyzy, R.C., Jackson, J.C., Khan, B., Malhotra, A., Masica, A.L., Owens, R.L., Pandharipande, P.P., Patel, M.B., Pisani, M.A., Pun, B.T., Rock, P., Schmidt, G.A., Schweickert, W.D., Stollings, J.L., Strength, C., Thompson, J.L.   +31 more
core   +1 more source

When the U Wave Tells the Story: Andersen–Tawil Syndrome Unmasked

Annals of Noninvasive Electrocardiology, Volume 30, Issue 6, November 2025.
Recurrent syncope in a young woman was diagnosed as Andersen‐Tawil syndrome (ATS), characterized by prominent U waves and prolonged QTU intervals. Genetic testing confirmed a KCNJ2 mutation. Tailored treatment, including medication adjustments, led to symptom improvement, emphasizing the importance of accurate diagnosis and management in ATS.
Shasha Yu, Hang Lv
wiley   +1 more source